Sen. Bernie Sanders (I-Vt.) has announced that a vote will be held on June 18 on whether to subpoena a senior executive from Novo Nordisk to appear before the Senate Health, Education, Labor and Pensions (HELP) Committee.
The vote will consider a subpoena for Doug Langa, executive vice president of North America Operations for the multinational firm, to testify about the cost of drugs Ozempic and Wegovy in the United States.
Mr. Sanders, who chairs the HELP committee, made the announcement on June 11 and during a floor speech he outlined the price differences between what pharmaceutical companies charge patients in the United States versus other countries. In many cases, the price was largely increased, as much as quadruple for patients in the United States….
Your point of view caught my eye and was very interesting. Thanks. I have a question for you.